Skip to main content

Oxford Ketone Ester For Appetite & Ghrelin Suppression Awareness Campaign Launch

A new awareness campaign has been announced by deltaG Ketones citing the scientific research behind the Oxford Ketone Ester. It explains that clinical trials have shown how ketones can suppress hunger and ghrelin.

The new announcement comes as ongoing research continues to show the importance of ketones across a broad range of fields. It discusses a human trial overseen by Brianna J Stubbs, Pete J Cox, Rhys D Evans, Malgorzata Cyranka, Kieran Clarke, and Heidi de Wet.

More information can be found at: https://www.deltagketones.com/pages/ketone-ester-clinical-trial

The impact of Ketone Ester on appetite suppression is central to the new awareness campaign. Participants in the trial fasted overnight before consuming a Ketone Ester or isocaloric dextrose. The Ketone Ester group experienced significantly lower levels of postprandial plasma insulin. It also suppressed hunger 90 minutes after consumption.

From this data, the team concluded that increased blood ketone levels may have a direct impact on appetite suppression. This expands the knowledge surrounding ketone intake and its potential use in both professional and recreational areas.

The National Library of Medicine has noted that elevated ketone levels attenuates neurobehavioral deficits and improves neuropathology. One recent human study concluded that ketones could be used during recovery to promote mTORC1 signaling and protein synthesis.

Another study highlighted the effect of ketones during times of high stress on the body and brain. It found that it improved physical performance and cognitive function while demonstrating energy-sparing properties.

The deltaG Ketones team explains that it provides the body and the brain with clean, efficient energy. This reduces the need for food consumption and focuses attention on more efficient fuel usage.

With its latest awareness campaign, deltaG Ketones underscores the work of Professor Kieran Clarke at the University of Oxford and Dr. Richard Veech at the National Institutes of Health.

The scientific research that helped to develop the Oxford-based program began in 2003. With an initial focus on assisting soldiers on the battlefield, the program has since expanded to athletes across fields.

A spokesperson for deltaG states: “Ketones are nature’s super fuel. When the body is pushed to its limits, we convert stored body fat into ketones for energy that help fuel the brain and body. Our revolutionary approach is unique in its potency, maximizing levels in the blood and providing a powerful fuel source that augments physical performance, sharpens mental acuity, and supports your metabolic health.”

Interested parties can learn more at: https://www.deltagketones.com/pages/ketone-ester-clinical-trial

Contact Info:
Name: Casey
Email: Send Email
Organization: deltaG Ketones
Address: 424 East Central Boulevard #204 SUITE:408B, Orlando, FL 32801, United States
Website: https://www.deltagketones.com/

Source: PressCable

Release ID: 89082247

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.